Currently out of the existing stock ratings of Biren Amin, 39 are a HOLD (19.5%), 160 are a BUY (80%), 1 are a SELL (0.5%).

Biren Amin

Work Performance Price Targets & Ratings Chart

Analyst Biren Amin, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 55.25% that have a potential upside of 30.96% achieved within 271 days. Previously, Biren Amin worked at JEFFERIES.

Biren Amin’s has documented 392 price targets and ratings displayed on 52 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on OCUL, Ocular Therapeutix at 02-Oct-2025.

Wall Street Analyst Biren Amin

Analyst best performing recommendations are on ZNTL (ZENTALIS PHARMACEUTICALS LLC).
The best stock recommendation documented was for ZNTL (ZENTALIS PHARMACEUTICALS LLC) at 5/18/2020. The price target of $44 was fulfilled within 1 day with a profit of $4.35 (10.97%) receiving and performance score of 109.71.

Average potential price target upside

of $1150.94 (27.43%) on TRVN (TREVENA).
of $59.42 (11.12%) on REGN (REGENERON PHARMACEUTICALS).
of $30.9 (16.85%) on CLDX (CELLDEX THERAPEUTICS).

AGEN Agenus ALKS Alkermes Plc ALLO Allogene Therapeutics BLCM Bellicum Pharmaceuticals BLUE Bluebird bio CCCC C4 Therapeutics CRTX Cortexyme FATE Fate Therapeutics HRTX Heron Therapeuti IMGN ImmunoGen MDCO The Medicines Company NBIX Neurocrine Biosciences NLNK NewLink Genetics REGN Regeneron Pharmaceuticals TRVN Trevena CLDX Celldex Therapeutics ACRX AcelRx Pharmaceuticals ANAB AnaptysBio CTMX CytomX Therapeutics IOVA Iovance Biotherapeutics LUMO Lumos Pharma KDMN Kadmon Holdings ZYNE Zynerba Pharmaceuticals STML Stemline Therapeutics XENE Xenon Pharmaceuticals ARDX Ardelyx GLYC GlycoMimetics KALA Kala Pharmaceuticals NK NantKwest OBSV ObsEva SA VSTM Verastem NERV Minerva Neurosciences ZNTL Zentalis Pharmaceuticals Llc ADVM Adverum Biotechnologies ACLX Arcellx APLS Apellis Pharmaceuticals IMNM Immunome SRPT Sarepta Therapeutics VKTX Viking Therapeutics CRGX CARGO Therapeutics, Common Stock ARCT Arcturus Therapeutics Holdings BBIO BridgeBio Pharma BCYC Bicycle Therapeutics Ltd CLLS Cellectis SA EQ Equillium IBRX Immunitybio IMTX Immatics NV LEGN Legend Biotech Corp NLTX Neoleukin Therapeutics MNPR Monopar Therapeutics OCUL Ocular Therapeutix SLDB Solid Biosciences LLC

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Emily Bodnar (HC WAINWRIGHT)